Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

Extended collaboration will further explore the capabilities of Medidata Platform from early-phase trials to post-marketing ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, looks back to 2024 and discusses some of the industry’s ...

“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...

Phase III HELIOS-B trial found that Amvuttra (vutrisiran) also preserved functional capacity and quality of life in patients ...

End-to-end offering is designed to streamline site activation and optimize visibility in critical research processes.

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...

Investigators find that most exclusion criteria in critical care randomized clinical trials are justifiable, but 60% include ...

Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...